Perturbations du comportement secondaires aux troubles neurocognitifs (SCPD) : Évaluation et prise en charge globale #085

Gardette, V., Lapeyre-Mestre, M., Coley, N., Cantet, C., Montastruc, J. L., Vellas, B., & Andrieu, S. (2012). Antipsychotic use and mortality risk in community-dwelling Alzheimer’s disease patients: evidence for a role of dementia severity. Curr Alzheimer Res, 9(9), 1106-1116. http://www.ncbi.nlm.nih.gov/pubmed/22950915